Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan:78:101173.
doi: 10.1016/j.drup.2024.101173. Epub 2024 Nov 21.

Post-translational modifications in drug resistance

Affiliations
Free article
Review

Post-translational modifications in drug resistance

Chenggui Miao et al. Drug Resist Updat. 2025 Jan.
Free article

Abstract

Resistance to antitumor drugs, antimicrobial drugs, and antiviral drugs severely limits treatment effectiveness and cure rate of diseases. Protein post-translational modifications (PTMs) represented by glycosylation, ubiquitination, SUMOylation, acetylation, phosphorylation, palmitoylation, and lactylation are closely related to drug resistance. PTMs are typically achieved by adding sugar chains (glycosylation), small proteins (ubiquitination), lipids (palmitoylation), or functional groups (lactylation) to amino acid residues. These covalent additions are usually the results of signaling cascades and could be reversible, with the triggering mechanisms depending on the type of modifications. PTMs are involved in antitumor drug resistance, not only as inducers of drug resistance but also as targets for reversing drug resistance. Bacteria exhibit multiple PTMs-mediated antimicrobial drug resistance. PTMs allow viral proteins and host cell proteins to form complex interaction networks, inducing complex antiviral drug resistance. This review summarizes the important roles of PTMs in drug resistance, providing new ideas for exploring drug resistance mechanisms, developing new drug targets, and guiding treatment plans.

Keywords: Acetylation; Drug resistance; Glycosylation; Post-transcriptional modification; Ubiquitination.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The corresponding author Zhe-sheng Chen is the Editor-in-Chief of Drug Resistance Updates, The researchers state that this investigation was carried out without any business or monetary connections that could be interpreted as possible conflicts of interest.

LinkOut - more resources